TABLE 2.
The MIC of fluconazole against 24 resistant and sensitive Candida albicans isolates as determined by broth microdilution testing (mg/ml)
| Candida albicans isolates | FLC MICs (mg/ml) | Type of cancer | |
|---|---|---|---|
| 1 | 21 | >64 | Liver |
| 2 | 36 | >64 | Gastric |
| 3 | 37 | >64 | Liver |
| 4 | 6 | 64 | Uterine |
| 5 | 49 | 64 | Colon |
| 6 | 23 | 64 | Breast |
| 7 | 16 | >64 | Leukemia |
| 8 | 42 | >64 | Lymphoma |
| 9 | 14 | 64 | Leukemia |
| 10 | 5 | >64 | Lymphoma |
| 11 | 70 | >64 | Uterine |
| 12 | 22 | >64 | Liver |
| 13 | 9 | 0.12 | Lymphoma |
| 14 | 3 | 0.12 | Breast |
| 15 | 11 | 0.25 | Gastric |
| 16 | 13 | 0.25 | Leukemia |
| 17 | 12 | 0.25 | Lymphoma |
| 18 | 33 | 0.25 | Bladder |
| 19 | 34 | 0.06 | Colon |
| 20 | 44 | 0.12 | Liver |
| 21 | 2 | 0.12 | Liver |
| 22 | 18 | 0.25 | Uterine |
| 23 | 4 | 0.5 | Leukemia |
| 24 | 19 | 0.25 | Gastric |